Fund profile
Tickers
FBDIX, FTDZX, FRBRX, FBTDX
Fund manager
Total assets
$915.12 mm
Liabilities
$18.58 mm
Net assets
$896.55 mm
Number of holdings
93.00
93 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
AMGN AMGEN Inc. | 76.40 mm | 243.11 k shares | 8.52 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 61.06 mm | 64.77 k shares | 6.81 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 53.32 mm | 123.04 k shares | 5.95 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 33.91 mm | 260.97 k shares | 3.78 | Common equity | Long | Denmark |
GILD Gilead Sciences, Inc. | 32.39 mm | 413.90 k shares | 3.61 | Common equity | Long | USA |
BIIB Biogen Inc | 31.90 mm | 129.34 k shares | 3.56 | Common equity | Long | USA |
Institutional Fiduciary Trust - Money Market Portfolio | 31.15 mm | 31.15 mm shares | 3.47 | Short-term investment vehicle | Long | USA |
ITCI Intra-Cellular Therapies Inc | 29.12 mm | 432.36 k shares | 3.25 | Common equity | Long | USA |
AstraZeneca plc
|
26.41 mm | 396.31 k shares | 2.95 | Common equity | Long | UK |
Jazz Pharmaceuticals plc
|
24.20 mm | 197.16 k shares | 2.70 | Common equity | Long | Ireland |
EYPT EyePoint Pharmaceuticals Inc | 23.59 mm | 876.13 k shares | 2.63 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 23.29 mm | 166.63 k shares | 2.60 | Common equity | Long | USA |
INSM Insmed Inc | 19.59 mm | 704.74 k shares | 2.19 | Common equity | Long | USA |
CBAY Cymabay Therapeutics Inc | 18.23 mm | 775.55 k shares | 2.03 | Common equity | Long | USA |
Institutional Fiduciary Trust Money Market Portfolio | 17.41 mm | 17.41 mm shares | 1.94 | Short-term investment vehicle | Long | USA |
ARGX Argen X SE | 16.93 mm | 44.49 k shares | 1.89 | Common equity | Long | Netherlands |
ILMN Illumina Inc | 16.33 mm | 114.19 k shares | 1.82 | Common equity | Long | USA |
Merus NV
|
15.98 mm | 447.83 k shares | 1.78 | Common equity | Long | Netherlands |
PCVX Vaxcyte Inc | 13.84 mm | 193.74 k shares | 1.54 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals Inc | 13.67 mm | 908.58 k shares | 1.53 | Common equity | Long | USA |
PTCT PTC Therapeutics Inc | 12.54 mm | 480.61 k shares | 1.40 | Common equity | Long | USA |
KROS Keros Therapeutics Inc | 12.20 mm | 220.45 k shares | 1.36 | Common equity | Long | USA |
CGEM Cullinan Therapeutics Inc | 11.85 mm | 783.02 k shares | 1.32 | Common equity | Long | USA |
MRNS Marinus Pharmaceuticals Inc | 11.70 mm | 1.20 mm shares | 1.30 | Common equity | Long | USA |
AVTR Avantor Inc. | 10.36 mm | 450.53 k shares | 1.16 | Common equity | Long | USA |
ALPN Alpine Immune Sciences Inc | 10.31 mm | 387.37 k shares | 1.15 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 9.92 mm | 345.35 k shares | 1.11 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 9.80 mm | 18.18 k shares | 1.09 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics Inc | 9.04 mm | 1.54 mm shares | 1.01 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 8.99 mm | 75.55 k shares | 1.00 | Common equity | Long | USA |
HLVX HilleVax Inc | 8.78 mm | 619.66 k shares | 0.98 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals Inc | 8.56 mm | 1.38 mm shares | 0.95 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals Inc | 8.27 mm | 312.59 k shares | 0.92 | Common equity | Long | USA |
DYN Dyne Therapeutics Inc | 7.61 mm | 355.43 k shares | 0.85 | Common equity | Long | USA |
IMVT Immunovant Inc | 7.56 mm | 207.71 k shares | 0.84 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals Inc | 7.15 mm | 446.59 k shares | 0.80 | Common equity | Long | USA |
GH Guardant Health Inc | 7.09 mm | 323.37 k shares | 0.79 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 6.72 mm | 122.03 k shares | 0.75 | Common equity | Long | Cayman Islands |
ABVX Abivax S.A. | 6.43 mm | 487.70 k shares | 0.72 | Common equity | Long | France |
SNDX Syndax Pharmaceuticals Inc | 5.71 mm | 278.90 k shares | 0.64 | Common equity | Long | USA |
SYRE Spyre Therapeutics Inc. | 5.70 mm | 220.00 k shares | 0.64 | Common equity | Long | USA |
PLRX Pliant Therapeutics Inc | 5.53 mm | 308.50 k shares | 0.62 | Common equity | Long | USA |
APGE Apogee Therapeutics Inc. | 5.48 mm | 163.54 k shares | 0.61 | Common equity | Long | USA |
KURA Kura Oncology Inc | 5.39 mm | 267.68 k shares | 0.60 | Common equity | Long | USA |
OCUL Ocular Therapeutix Inc | 5.09 mm | 1.05 mm shares | 0.57 | Common equity | Long | USA |
STTK Shattuck Labs Inc | 4.98 mm | 527.10 k shares | 0.56 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals Inc | 4.90 mm | 77.48 k shares | 0.55 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals Inc | 4.78 mm | 130.92 k shares | 0.53 | Common equity | Long | USA |
RVNC Revance Therapeutics Inc | 4.75 mm | 943.66 k shares | 0.53 | Common equity | Long | USA |
Pipeline Therapeutics, Inc., Series C
|
4.67 mm | 1.65 mm shares | 0.52 | Common equity | Long | USA |
IRON Disc Medicine Inc | 4.50 mm | 68.43 k shares | 0.50 | Common equity | Long | USA |
NUVL Nuvalent Inc - Ordinary Shares | 4.33 mm | 57.55 k shares | 0.48 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc | 4.22 mm | 93.36 k shares | 0.47 | Common equity | Long | Canada |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 4.08 mm | 46.29 k shares | 0.45 | Common equity | Long | USA |
CYTK Cytokinetics Inc | 3.83 mm | 49.02 k shares | 0.43 | Common equity | Long | USA |
CRGX CARGO Therapeutics Inc | 3.79 mm | 172.19 k shares | 0.42 | Common equity | Long | USA |
CGON Cg Oncology Inc. | 3.79 mm | 101.60 k shares | 0.42 | Common equity | Long | USA |
TERN Terns Pharmaceuticals Inc | 3.76 mm | 725.03 k shares | 0.42 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc | 3.53 mm | 80.83 k shares | 0.39 | Common equity | Long | Cayman Islands |
Applied Therapeutics, Inc.
|
3.47 mm | 1.63 mm shares | 0.39 | Common equity | Long | USA |
Sartorius AG | 3.36 mm | 9.20 k shares | 0.37 | Preferred equity | Long | Germany |
Applied Therapeutics, Inc.
|
3.16 mm | 1.01 mm shares | 0.35 | Common equity | Long | USA |
MLYS Mineralys Therapeutics Inc | 3.05 mm | 279.55 k shares | 0.34 | Common equity | Long | USA |
ANAB AnaptysBio Inc | 3.01 mm | 127.52 k shares | 0.34 | Common equity | Long | USA |
HRTX Heron Therapeutics Inc | 2.88 mm | 1.20 mm shares | 0.32 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 2.79 mm | 63.32 k shares | 0.31 | Common equity | Long | USA |
APLT Applied Therapeutics Inc | 2.72 mm | 867.85 k shares | 0.30 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals Inc | 2.57 mm | 234.00 k shares | 0.29 | Common equity | Long | USA |
Applied Therapeutics, Inc.
|
2.55 mm | 814.00 k shares | 0.28 | Common equity | Long | USA |
ETNB 89bio Inc | 2.52 mm | 254.24 k shares | 0.28 | Common equity | Long | USA |
Alto Neuroscience, Inc., Series C
|
2.48 mm | 367.13 k shares | 0.28 | Common equity | Long | USA |
AURA Aura Biosciences Inc | 2.17 mm | 282.30 k shares | 0.24 | Common equity | Long | USA |
ABOS Acumen Pharmaceuticals Inc | 2.14 mm | 674.00 k shares | 0.24 | Common equity | Long | USA |
TXG 10x Genomics Inc - Ordinary Shares | 2.14 mm | 51.40 k shares | 0.24 | Common equity | Long | USA |
Roivant Sciences Ltd.
|
1.98 mm | 197.90 k shares | 0.22 | Common equity | Long | Bermuda |
SLRN Acelyrin Inc | 1.96 mm | 257.39 k shares | 0.22 | Common equity | Long | USA |
ALEC Alector Inc | 1.81 mm | 303.35 k shares | 0.20 | Common equity | Long | USA |
JSPR Jasper Therapeutics Inc | 1.70 mm | 144.57 k shares | 0.19 | Common equity | Long | USA |
CNTA Centessa Pharmaceuticals plc | 1.55 mm | 189.74 k shares | 0.17 | Common equity | Long | UK |
GPCR Structure Therapeutics Inc | 1.51 mm | 34.63 k shares | 0.17 | Common equity | Long | Cayman Islands |
CNTA Centessa Pharmaceuticals plc | 1.35 mm | 165.03 k shares | 0.15 | Common equity | Long | UK |
ADVM Adverum Biotechnologies Inc | 1.21 mm | 1.16 mm shares | 0.14 | Common equity | Long | USA |
CTLT Catalent Inc. | 1.17 mm | 22.70 k shares | 0.13 | Common equity | Long | USA |
FUSN Fusion Pharmaceuticals Inc | 1.04 mm | 89.10 k shares | 0.12 | Common equity | Long | Canada |
BNTC Benitec Biopharma Inc | 1.03 mm | 364.89 k shares | 0.11 | Common equity | Long | USA |
Artiva Biotherapeutics, Inc., Class B
|
931.54 k | 189.50 k shares | 0.10 | Common equity | Long | USA |
Benitec Biopharma, Inc.
|
873.54 k | 310.88 k shares | 0.10 | Common equity | Long | USA |
Carmot Therapeutics, Inc.
|
219.46 k | 83.10 k shares | 0.02 | Common equity | Long | USA |
RLMD Relmada Therapeutics Inc | 200.23 k | 50.95 k shares | 0.02 | Common equity | Long | USA |
Benitec Biopharma, Inc.
|
141.87 k | 310.88 k shares | 0.02 | Common equity | Long | USA |
BNTC Benitec Biopharma Inc | 95.23 k | 7.02 mm shares | 0.01 | Long | Australia | |
NUVB Nuvation Bio Inc - Ordinary Shares | 10.36 k | 115.27 k shares | 0.00 | Long | USA | |
Sanofi SA, Escrow Account
|
0 | 2.33 mm shares | 0.00 | Common equity | Long | Colombia |